8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)
Published . Updated .
Filed: 2026-10-14 AccNo: 0001398733-26-000056 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Directly affected
- AQST Aquestive Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-14 AccNo: 0001398733-26-000056 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 14 Oct 2026: Aquestive Therapeutics (AQST) versus the S&P 500
Since the first closing price after “8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer),” Aquestive Therapeutics (AQST) is -5.41%. The S&P 500 fund (SPY) is -0.67% over the same days, a -4.74% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Aquestive Therapeutics (AQST) | that day | -1.50% | final price |
| Aquestive Therapeutics (AQST) | the next day | -13.14% | final price |
| Aquestive Therapeutics (AQST) | two days later | -19.44% | final price |
| Aquestive Therapeutics (AQST) | three days later | -17.84% | final price |
| Aquestive Therapeutics (AQST) | three days earlier | +1.92% | final price |
| Aquestive Therapeutics (AQST) | five days earlier | -1.50% | final price |
| GLD | that day | -1.49% | final price |
| GLD | the next day | +0.27% | final price |
| GLD | two days later | +0.10% | final price |
| GLD | three days later | -0.52% | final price |
| GLD | three days earlier | +0.77% | final price |
| GLD | five days earlier | -1.52% | final price |
| QQQ | that day | -1.97% | final price |
| QQQ | the next day | -2.08% | final price |
| QQQ | two days later | -4.55% | final price |
| QQQ | three days later | -3.41% | final price |
| QQQ | three days earlier | +1.02% | final price |
| QQQ | five days earlier | +1.90% | final price |
| SPY | that day | -1.08% | final price |
| SPY | the next day | -0.80% | final price |
| SPY | two days later | -1.89% | final price |
| SPY | three days later | -1.47% | final price |
| SPY | three days earlier | +0.06% | final price |
| SPY | five days earlier | -0.11% | final price |
| TLT | that day | +0.68% | final price |
| TLT | the next day | +2.09% | final price |
| TLT | two days later | +2.15% | final price |
| TLT | three days later | +1.42% | final price |
| TLT | three days earlier | -0.50% | final price |
| TLT | five days earlier | -1.52% | final price |
Who gains and who loses around Aquestive Therapeutics (AQST)
Companies tied to this story
- AQST Aquestive Therapeutics
In “8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer),” Aquestive Therapeutics (AQST) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> AQST
How “8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)” reaches Aquestive Therapeutics (AQST)
Aquestive Therapeutics (AQST) is the company in “8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer),” the 14 Oct 2026 this story story.
Aquestive Therapeutics (AQST) is on the page because SEC 8-K filing -> direct issuer disclosure -> AQST
Price levels for Aquestive Therapeutics (AQST)
AQST traded between 3.65 and 5.10 across 20 sessions. The latest close on file is 3.85.
How solid “8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)” looks
44 out of 100
“8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)” scores 44 out of 100. The score uses 1 sources, a -12.34% difference versus the S&P 500 (SPY), and 1 linked companies.